The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Biomodulatory approaches to photodynamic therapy for solid tumors
Open accessAbstract
Photodynamic Therapy (PDT) uses a photosensitizing drug in combination with visible light to kill cancer cells. PDT has an advantage over surgery or ionizing radiation because PDT can eliminate tumors without causing fibrosis or scarring. Disadvantages include the dual need for drug and light, and a generally lower efficacy for PDT versus surgery. This minireview describes basic principles of PDT, photosensitizers available, and aspects of tumor biology that may provide further opportunities for treatment optimization. An emerging biomodulatory approach, using methotrexate or Vitamin D in combination with aminolevulinate-based PDT, is described. Finally, current clinical uses of PDT for solid malignancies are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Photodynamic therapy with endogenous protoporphyrin
Kennedy, J. C., Pottier, R. H., & Pross, D. C. (1990) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(90)85083-9 · Cited by 1,509
Oxygen Consumption and Diffusion Effects in Photodynamic Therapy
Foster, T. H., Murant, R. S., Bryant, R. G., Knox, R. S., Gibson, S. L., & Hilf, R. (1991) · Radiation Research · doi:10.2307/3577919 · Cited by 400
Pain associated with aminolevulinic acid-photodynamic therapy of skin disease
Warren, C. B., Karai, L. J., Vidimos, A., & Maytin, E. V. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.048 · Cited by 136
Self-citationSinha, A. K., Anand, S., Ortel, B. J., Chang, Y., Mai, Z., Hasan, T., & Maytin, E. V. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603273 · Cited by 114
Self-citationCurnow, A., Mcllroy, B., Postle-Hacon, M., Porter, J., MacRobert, A., & Bown, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.671 · Cited by 68
Choudry, K., Brooke, R. C. C., Farrar, W., & Rhodes, L. E. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05351.x · Cited by 65
Silencing of ALA dehydratase affects ALA-photodynamic therapy efficacy in K562 erythroleukemic cells
Feuerstein, T., Schauder, A., & Malik, Z. (2009) · Photochemical & Photobiological Sciences · doi:10.1039/b9pp00007k · Cited by 19
Cited by
Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics
Singh, S., Aggarwal, A., Bhupathiraju, N. V. S. D. K., Arianna, G., Tiwari, K., & Drain, C. M. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00244 · Cited by 563
Photodynamic therapy in cancer treatment - an update review
Dos Santos, A. F., De Almeida, D. R. Q., Terra, L. F., Baptista, M. S., & Labriola, L. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.83 · Cited by 446
Chemophototherapy: An Emerging Treatment Option for Solid Tumors
Luo, D., Carter, K. A., Miranda, D., & Lovell, J. F. (2017) · Advanced Science · doi:10.1002/advs.201600106 · Cited by 436
Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
Huggett, M. T., Jermyn, M., Gillams, A., Illing, R., Mosse, S., Novelli, M., Kent, E., Bown, S. G., Hasan, T., Pogue, B. W., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.95 · Cited by 396
Self-citationReversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
Yin, Q., Shen, J., Zhang, Z., Yu, H., & Li, Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.04.011 · Cited by 365
Metadata
- Authors
- Anand, S., Ortel, B. J., Pereira, S. P., Hasan, T., & Maytin, E. V.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 326
- Issue
- 1
- Pages
- 8-16
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2107437510
- Cited by
- 160
- References
- 8
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.